News

6MWT changes from baseline to visit 6

New publication: Safety and Treatment Effects of Nusinersen in Longstanding Adult 5q-SMA Type 3 – A Prospective Observational Study

We are pleased to have been involved in this new publication showing that the SMA drug nusinersen also benefits adults with 5q spinal muscular atrophy. Although the drug has received regulatory approval without age restrictions, many countries restrict reimbursement to paediatric patients, where the benefits are often more substantial and...
Journal of Neuromuscular Diseases

Latest edition of the Journal of Neuromuscular Diseases now online – Nov 2019

A new issue of the Journal of Neuromuscular Diseases has recently been released. It features a number of open-access reviews on cardiac magnetic resonance in muscular dystrophies and axonal transport defects in inherited neuropathies, and a comprehensive review of dog models for neuromuscular disease. Read it below: Journal of Neuromuscular...
yakup

The power of diagnosis – watch “Yakup’s journey to hope”

A genetic diagnosis brings so much to families - and sometimes allows an effective treatment to be initiated. We are delighted that one of our joint projects is featured in this video created by the Global Alliance for Genomics and Health and European Joint Programme on Rare Diseases. In this initiative funded...
Picture1

New Publication: Congenital myasthenic syndrome with mild intellectual disability caused by a recurrent SLC25A1 variant

We were pleased to collaborate with colleagues in the UK, India, Germany, and Spain on this brief communication reporting three additional families with congenital myasthenic syndrome (CMS) all harbouring the same homozygous missense variant in SLC25A1, confirming this as a CMS-associated gene. Interestingly the patients  with more severe mutations also...
MITO2019 poster V3

Conference Announcement: MITO2019 in Toronto 8-9th Nov

MITO2019 is the annual meeting for mitoNET and the MitoCanada Foundation and serves as the main education & networking event for mitoNET. This year it is being held at the Courtyard by Marriott Downtown hotel in Toronto. With a theme of “The Power of Mitochondria to transform human health”, it...
Picture2

A new arrival accompanied by a new publication

The Lochmüller lab is pleased to welcome Dr. Emily O'Connor to the group in Ottawa. Emily marked her arrival in the best possible way, with a new publication in the journal Cells, as part of their special issue entitled 150 Years of Motor Endplate: Molecules, Cells, and Relevance of a...
cecilia_edit

New Publication: Analysis of the functional capacity outcome measures for myotonic dystrophy

Being able to accurately and reliably asses functional capacity in people with myotonic dystrophy type 1 (DM1) is paramount to monitor disease progression and assess the effects of therapeutic interventions. However, this can be problematic when patients have differing severities of symptoms, ages of onset, body compositions, and sex. For...
Hanns-crc

Foundation grant success for the Lochmüller Lab!

We are thrilled to announce that our Foundation Grant application on Precision Health for Neuromuscular Diseases (NMD) has been funded in the Canadian Institute for Health Research's 2018 - 2019 competition. The overarching goal of our translational research program funded through this award is to understand the molecular pathogenesis of...
deduplicating

New publication: De-duplicating patient records from three independent data sources reveals the incidence of rare neuromuscular disorders in Germany

Patients with long-term, complex conditions like neuromuscular diseases may receive diagnosis, care and treatment in several different centres, each of which then holds an individual piece of the patient's complete medical record.  These records must be kept confidential to protect the patient's privacy, but these important privacy restrictions also make...
Figure_1_sm

New publication: Increasing phenotypic annotation improves the diagnostic rate of exome sequencing in a rare neuromuscular disorder

How can we use phenotypic descriptions to aid genetic diagnosis starting with hundreds of rare variants from next-generation sequencing results? How comprehensively should a doctor annotate a patient's phenotype to help identify the causative variant? These questions are increasingly relevant for doctors seeing undiagnosed patients, but data showing how phenotypic...
Hanns-crc

Hanns Lochmüller is awarded prestigious Tier 1 Canada Research Chair in neuromuscular genomics and health

We are thrilled to announce that Hanns has been awarded a Canada Research Chair (CRC) in Neuromuscular Genomics and Health. The announcement was made at a ceremony at the University of Victoria at noon today. The prestigious Tier 1 CRC awards are for outstanding researchers acknowledged by their peers as...
Emily_Oconnor15

PhD Viva Success

We are delighted to announce the success of one of Hanns's UK students. Emily O'Connor, jointly supervised by Hanns and Professor Clarke Slater, successfully defended her thesis work this week and will be awarded a PhD from Newcastle University following submission of minor corrections. Emily was awarded her PhD for...
ENMC_SDM

New publication: “Be an ambassador for change that you would like to see”: a call to action to all stakeholders for co-creation in healthcare and medical research to improve quality of life of people with a neuromuscular disease

The 2018 ENMC workshop on shared decision-making has resulted in a second valuable publication on the importance of co-creation in healthcare and medical research. In this new article by Ambrosini et al, workshop participants report on their discussions and conclusions on how to make all stakeholders, particularly the patients themselves,...
Picture1

Double PhD Viva Success

We are thrilled to announce the success of two of Hanns's UK students. Grace McMacken and Rachel Thompson defended their PhD work this week and will be awarded PhDs from Newcastle University following submission of minor corrections. Both have attained their PhDs by published work, Grace on "Congenital Myasthenic Syndromes...
COL13A1 continum

New publication: The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations

We were pleased to be part of this collaborative effort spearheaded by Pedro M. Rodrıguez Cruz and David Beeson to characterize the mutational and clinical spectrum of congenital myasthenic syndromes (CMS) associated with mutations in COL13A1. This study, which spanned multiple countries, provides a detailed description of the clinical features...
IMG-20190505-WA0000

Lochmüller Lab in the annual Cycle for CHEO

On May 5th, Lochmüller lab & Friends completed the annual Cycle for CHEO ride in Ottawa. They rode as part of a 45 strong CHEO Researchers in Motion Team that together raised more than $11,000. The local police and over 500 volunteers helped with road closures and support throughout the...